Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
REGENXBIO Inc. (RGNX)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Source | Source | Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Asset turnover | 0.1 | 0.5 | 0.3 | 0.1 | 0.5 | 0.0 | 0.0 | 0.1 |
|
Returns on Capital |
ROIC (excluding intangibles) | -44.2% | 26.6% | -31.6% | -34.1% | 28.7% | -54.3% | -42.5% | -28.7% |
ROIC (including intangibles) | -45.8% | 19.5% | -36.4% | -36.4% | 18.8% | -54.2% | -46.5% | -14.0% |
ROE | -54.2% | 16.7% | -29.4% | -32.2% | 16.6% | -41.5% | -40.1% | -10.7% |
ROA | -33.6% | 11.5% | -15.7% | -29.1% | 15.6% | -38.2% | -37.6% | -10.5% |
|
Cash Conversion Cycle |
Days sales outstanding | 90.9 | 25.2 | 101.5 | 395.2 | 0.0 | 0.0 | 0.0 | 0.0 |
Days payables outstanding | 182.1 | 80.2 | 108.6 | 283.9 | 167.1 | 1,032.0 | 587.3 | 246.2 |
Cash conversion cycle | -91.2 | -55.0 | -7.0 | 111.3 | -167.1 | -1,032.0 | -587.3 | -246.2 |
|